Literature DB >> 6422513

Thyrotropin-releasing hormone injected intracerebroventricularly in the rat stimulates exocrine pancreatic secretion via the vagus nerve.

Y Kato, T Kanno.   

Abstract

The effects of intracerebroventricular (i.c.v.) injection of synthetic thyrotropin-releasing hormone (TRH) and its analogue (gamma-butyrolactone-gamma-carbonyl-His-Pro-NH2) were tested in anesthetized rats fitted with pancreatic cannula. TRH injection induced dose-related increases in flow of pancreatic juice, protein output, and amylase output, each reaching a maximum within 10 min. Higher doses of TRH induced longer responses. Injection of the TRH analogue also caused dose-related secretory responses of the exocrine pancreas. The dose-related secretory responses to TRH and the TRH analogue were similar except that the responses to the highest dose of TRH analogue (1600 pmol/100 g b.w.) were significantly higher. Intravenous injection of TRH and the TRH analogue induced little, if any, secretory response of the exocrine pancreas. The effects of i.c.v. injection of TRH and the TRH analogue were completely abolished after bilateral subdiaphragmatic vagotomy. In addition to the secretory effects on the exocrine pancreas, i.c.v. injection of TRH and the analogue caused hyperglycemia, tachycardia, and tear secretion, but the intravenous injection of these peptides had no effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6422513     DOI: 10.1016/0167-0115(83)90106-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

Review 1.  Neurobiology of brain-gut interactions. Implications for ulcer disease.

Authors:  D E Hernandez
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

2.  Neuropeptides TRH and cyclo(His-Pro) share neuromodulatory, but not stimulatory, action on hypothalamic neurons in vitro: implication for the regulation of feeding.

Authors:  L M Kow; D W Pfaff
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

3.  Evolution of atenolol kinetics when hypothyroidism is corrected.

Authors:  H Levesque; M O Richard; J Fresel; A Gancel; N Moore; H Courtois
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.